THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

Show other versions (1)

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-layout-grid-align: none;"><span lang="EN-GB" style="font-size: 10pt; line-height: 150%; font-family: Arial; mso-ansi-language: EN-GB;">Seco...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandra Tedeschi, Francesca Ricci, Marco Montillo, Enrica Morra
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-01-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Secondary myelodisplasia, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
Online Access:	http://www.mjhid.org/article/view/8251
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Francesca Ricci, et al.
Published: (2011-07-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024-12-01)

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment
by: Karima Amaador, et al.
Published: (2023-02-01)

CORRIGENDUM: Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Gilda Cennamo, et al.
Published: (2024-12-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature
by: Riccardo Paggi, et al.
Published: (2023-04-01)

Mismatches in optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study
by: Sunny Chi Lik Au
Published: (2024-12-01)

BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE
by: Marzia Varettoni, et al.
Published: (2017-10-01)

As a Cause of Fever Unknown Origin, Waldenstrom's Macroglobulinemia: a Case Report
by: mehmet ozen, et al.
Published: (2014-08-01)

Refractory IgM AL amyloidosis with massive soft tissue tumors: Rescue with zanubrutinib. A case report
by: Piotr Jachimowski, et al.
Published: (2024-12-01)

Fasting and Diet: Overview in Chronic Lymphocytic Leukemia
by: Alessandra Trojani, et al.
Published: (2024-10-01)

THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti
Published: (2013-04-01)

Simultaneous Chronic Lymphocytic Leukemia and Hairy Cell Leukemia: a Sporadic Event? A Semantic Point of View.
by: luiza akria, et al.
Published: (2014-08-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Patrizia Chiusolo, et al.
Published: (2010-05-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01)

Laboratory analysis of 124 chronic lymphocytic leukemia cases: Single center study
by: Shams Salah Mahdi, et al.
Published: (2024-12-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Caterina Giovanna Valentini, et al.
Published: (2011-12-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Morena Caira, et al.
Published: (2011-01-01)

An Urologic Face of Chronic Lymphocytic Leukemia:Sequential Prostatic and Penis Localization
by: Giovanni D'Arena, et al.
Published: (2013-01-01)

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: Lorenzo Falchi, et al.
Published: (2016-02-01)

WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS
by: Michele Bibas, et al.
Published: (2024-06-01)

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors
by: Peter Georgantopoulos, et al.
Published: (2019-05-01)

Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
by: Rafeea Shah, et al.
Published: (2024-10-01)

A Study of Differential Transcriptome Expression in CD8+ T Cells in Chronic Lymphocytic Leukemia
by: Mahdieh Darvish-Khezri, et al.
Published: (2024-10-01)

Serum Beta-2 Microglobulin as Biomarker in Chronic Lymphocytic Leukemia
by: Nora M. Mahgoub, et al.
Published: (2024-12-01)

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases
by: Igor Aurer, et al.
Published: (2024-12-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01)

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia
by: Juan A. Piñeyroa, et al.
Published: (2024-11-01)

Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts
by: Alexandre Malek
Published: (2020-06-01)

Chronic lymphocytic leukemia and JAK2 V617F positive essential thrombocythemia: Distinct clonal diseases?
by: Deniz Çetin, et al.
Published: (2014-08-01)

BCL2i-Based Therapies and Emerging Resistance in Chronic Lymphocytic Leukemia
by: Wing Fai Li, et al.
Published: (2024-11-01)

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study
by: Changyu Jin, et al.
Published: (2025-01-01)

“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
by: Sara Martinelli, et al.
Published: (2016-10-01)

RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?
by: Antonio Cuneo, et al.
Published: (2019-02-01)

A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia
by: Michela Flego, et al.
Published: (2025-01-01)

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges
by: Sofija Kozarac, et al.
Published: (2025-01-01)

Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia
by: Tong-Yoon Kim, et al.
Published: (2025-01-01)

T-cell Large Granular Lymphocytic Leukemia Manifesting in Patients with HIV-1 Infection: Cases Series and Review of the Literature
by: Ashley M Rose, et al.
Published: (2018-06-01)